AGIO

Agios Pharmaceuticals, Inc. · NASDAQ

Sector Health Technology
Industry Pharmaceuticals: Major
Website agios.com
Employees(FY) 389
ISIN US00847X1046

Performance

+25.48%

+37.4%

+30.98%

+77.58%

+163.13%

YTD

+174.6%

Profile

Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism. The company develops PYRUKYND (mitapivat), an activator of wild-type and mutant pyruvate kinase (PK), enzymes for the treatment of hemolytic anemias; and AG-946, a PK activator for treating lower-risk myelodysplastic syndrome and hemolytic anemias. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.

Advanced Technical Analysis

Technical Analysis of AGIO 2024-11-13

The stock exhibits a strong bullish sentiment with a Moving Average Score of 90, indicating robust upward momentum, while the Technical Score of 70 further supports this positive outlook; however, the neutral Oscillators Score of 50 suggests a potential consolidation phase that investors should monitor. Overall, the combination of these scores p...

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of AGIO

Stock Rank

Recent News & Updates

2024-11-07 06:57
Agios Pharmaceuticals (NASDAQ:AGIO) Is Posting Healthy Earnings, But It Is Not All Good News(Simply Wall St.)
2024-11-05 09:05
Agios to Present New Data on Mitapivat and Tebapivat in Rare Blood Disorders at 66th ASH Annual Meeting and Exposition(GlobeNewswire)
2024-11-04 20:05
Agios to Present New Data on Mitapivat and Tebapivat in Rare Blood Disorders at 66th ASH Annual Meeting and Exposition(Globenewswire)
2024-11-01 10:47
AGIO's Q3 Earnings Miss Mark, Revenues In Line, Stock Down(Zacks)
2024-11-01 09:40
Is ADC Therapeutics (ADCT) Stock Outpacing Its Medical Peers This Year?(Zacks)
2024-11-01 08:57
Agios Pharmaceuticals Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag(Simply Wall St.)
2024-11-01 03:03
Agios Pharmaceuticals Inc (AGIO) Q3 2024 Earnings Call Highlights: Strong Cash Position and ...(GuruFocus.com)
2024-10-31 10:34
Agios Pharmaceuticals Shares Fall After Q3 Revenue Miss(MT Newswires)
2024-10-31 06:42
Agios Pharmaceuticals: Q3 Earnings Snapshot(Associated Press Finance)
2024-10-31 06:30
Agios Reports Business Highlights and Third Quarter 2024 Financial Results(GlobeNewswire)
2024-10-30 19:45
Agios Pharmaceuticals (AGIO) Misses Q3 Earnings and Revenue Estimates(Yahoo Finance)
2024-10-30 18:30
Agios Reports Business Highlights and Third Quarter 2024 Financial Results(Globenewswire)
2024-10-23 07:00
Agios Completes Enrollment of Phase 3 RISE UP Study of Mitapivat in Sickle Cell Disease(GlobeNewswire)
2024-10-22 19:00
Agios Completes Enrollment of Phase 3 RISE UP Study of Mitapivat in Sickle Cell Disease(Globenewswire)
2024-10-17 07:00
Agios to Webcast Conference Call of Third Quarter 2024 Financial Results on October 31, 2024(GlobeNewswire)
2024-10-16 19:00
Agios to Webcast Conference Call of Third Quarter 2024 Financial Results on October 31, 2024(Globenewswire)
2024-10-16 08:03
Scotiabank Initiates Agios Pharmaceuticals at Sector Outperform With $51 Price Target(MT Newswires)
2024-09-27 11:29
Agios Pharmaceuticals' Shares Fall After Downgrade From Leerink Partners(MT Newswires)
2024-09-27 10:34
Do Options Traders Know Something About Agios (AGIO) Stock We Don't?(Zacks)
2024-09-27 07:28
Leerink Partners Downgrades Agios Pharmaceuticals to Market Perform From Outperform, Price Target is $56(MT Newswires)
2024-09-26 16:05
Pfizer Tanked A $5.4 Billion Takeover. Why Crispr, Agios, Beam Could Benefit.(Investor's Business Daily)
2024-09-17 07:56
Agios Pharmaceuticals (AGIO) Appreciated after Positive Testing Results(Insider Monkey)
2024-09-14 08:28
Companies Like Agios Pharmaceuticals (NASDAQ:AGIO) Are In A Position To Invest In Growth(Simply Wall St.)
2024-09-12 11:33
FDA Grants Orphan Drug Tag to AGIO's Tebapivat for Rare Cancer(Zacks)
2024-09-12 06:33
Agios Pharmaceuticals’ tebapivat gains FDA orphan drug designation(Pharmaceutical Technology)
2024-09-11 07:36
Agios Pharmaceuticals Says FDA Granted Orphan Drug Designation to Blood Disorder Drug Candidate Tebapivat(MT Newswires)
2024-09-11 07:00
Agios Announces FDA Orphan Drug Designation Granted to Tebapivat (AG-946) for Treatment of Myelodysplastic Syndromes (MDS)(GlobeNewswire)
2024-09-10 19:00
Agios Announces FDA Orphan Drug Designation Granted to Tebapivat (AG-946) for Treatment of Myelodysplastic Syndromes (MDS)(Globenewswire)
2024-09-06 11:31
Why Is Zimmer (ZBH) Down 3.9% Since Last Earnings Report?(Zacks)
2024-09-05 07:00
Agios to Present at the 2024 Cantor Global Healthcare Conference on September 18, 2024(GlobeNewswire)

Page 1 of 9

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.